Chemical Nameteduglutide
Dosage FormInjection (subcutaneous; 5mg)
Drug ClassAnalogs
CompanyTakeda Pharmaceutical Company Limited
Approval Year2012


  • For the treatment of with Short Bowel Syndrome (SBS) who are dependent on parenteral support in adults and pediatric patients 1 year of age and older.
Last updated on 5/11/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Gattex (teduglutide) Prescribing Information2012Shire-NPS Pharmaceuticals, Inc., Lexington, MA